ADVENTRX to Present at BIOCOM San Diego Investor Conference
November 14 2006 - 6:00AM
PR Newswire (US)
SAN DIEGO, Nov. 14 /PRNewswire-FirstCall/ -- ADVENTRX
Pharmaceuticals, Inc. (AMEX:ANX) announced today that Evan M.
Levine, chief executive officer, will deliver a corporate
presentation at the BIOCOM San Diego Investor Conference on
Wednesday, November 15, 2006 at 3:20 p.m. Pacific Time (6:20 pm
Eastern Time). A link to the live audio webcast will be available
via the "Investors" section of the Company's Web site at
http://www.adventrx.com/ under "Events". The replay of the
corporate presentation will be available for 14 days following the
event. The BIOCOM San Diego Investor Conference will take place on
November 14-16, 2006 at the San Diego Marriott in Del Mar, CA.
About ADVENTRX ADVENTRX Pharmaceuticals is a biopharmaceutical
research and development company focused on introducing treatments
for cancer and infectious disease that surpass the performance and
safety of existing drugs, by addressing significant problems such
as drug metabolism, toxicity, bioavailability and resistance. More
information can be found on the Company's Web site at
http://www.adventrx.com/. Forward Looking Statement This press
release contains forward-looking statements, within the meaning of
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995, regarding ADVENTRX. Such statements are made
based on management's current expectations and beliefs. Actual
results may vary from those currently anticipated based upon a
number of factors, including uncertainties inherent in the drug
development process, the timing and success of clinical trials, the
validity of research results, and the receipt of necessary
approvals from the FDA and other regulatory agencies. For a
discussion of such risks and uncertainties, which could cause
actual results to differ from those contained in the
forward-looking statements regarding ADVENTRX, see the section
titled "Risk Factors" in ADVENTRX's last annual report on Form 10-K
and its Quarterly Reports on Form 10-Q, as well as other reports
that ADVENTRX files from time to time with the Securities and
Exchange Commission. All forward-looking statements regarding
ADVENTRX are qualified in their entirety by this cautionary
statement. ADVENTRX undertakes no obligation to release publicly
any revisions to forward-looking statements to reflect events or
circumstances which occur after the date hereof. DATASOURCE:
ADVENTRX Pharmaceuticals, Inc. CONTACT: Ioana Hone for ADVENTRX
Pharmaceuticals, +1-858-552-0866 Web site: http://www.adventrx.com/
Copyright
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jul 2023 to Jul 2024